Global Needle Free Injection Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product;

Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors.

By Technology;

Jet-Based, Spring-Based, and Laser-Powered.

By Usability;

Reusable Needle-Free Injectors and Disposable Needle-Free Injectors.

By End User;

Hospitals And Clinics , Ambulatory Surgical Centres, and Homecare Settings.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn370421019 Published Date: November, 2024 Updated Date: December, 2024

Introduction

Global Needle Free Injection Market (USD Million), 2020 - 2030

In the year 2023, the Global Needle Free Injection Market was valued at USD 1,283.50 million. The size of this market is expected to increase to USD 2,408.61 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 9.4%.

The COVID-19 pandemic has spurred a positive impact on the needle-free injectors market, primarily driven by the escalating demand for mass vaccination campaigns and self-administrable devices in response to the crisis. As COVID-19 cases surged globally, numerous players in the needle-free injectors market intensified their research and development endeavors, forging partnerships and agreements with industry peers and governmental bodies to enhance and innovate needle-free injector technologies.

Needle-free injectors offer heightened safety for both patients and healthcare workers by eliminating the risks associated with conventional injection methods, including drug preparation, needle insertion, and needle disposal. According to the American Nurses Association, approximately 74.0% of accidental needlestick injuries result from contamination, raising concerns about potential infections. Treating such injuries incurs significant expenses, with costs ranging from USD 500 to USD 3,000 per incident, as projected by the CDC, which estimates an annual count of 385,000 needlestick injuries in U.S. hospitals alone. Moreover, the European Agency for Safety and Health at Work reports approximately 1.0 million needlestick injuries worldwide annually.

The escalating healthcare costs pose a significant challenge for both developing and developed economies. Despite substantial investments in health funding and insurance programs, healthcare expenditures in the U.S. are approximately 2.4 times higher than the global average and are expected to surge by 68.0% over the next decade. In this context, needle-free injectors offer a promising solution by enabling patients to self-administer medications subcutaneously at home, potentially reducing the need for hospital visits and mitigating healthcare expenses. This trend aligns with efforts to deliver cost-effective and quality care, addressing the mounting concerns over healthcare affordability and accessibility.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Usability
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Needle Free Injection Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Reduced Risk of Needle-Stick Injuries
        2. Improved Vaccine Delivery
        3. Technological Advancements
      2. Restraints
        1. High Cost
        2. Reimbursement Issues
        3. Limited Applications
      3. Opportunities
        1. Homecare Applications
        2. Focus on Innovation
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Needle Free Injection Market, By Product, 2020 - 2030 (USD Million)
      1. Fillable Needle-Free Injectors
      2. Prefilled Needle-Free Injectors
    2. Global Needle Free Injection Market, By Technology, 2020 - 2030 (USD Million)
      1. Jet-Based
      2. Spring-Based
      3. Laser-Powered
    3. Global Needle Free Injection Market, By Usability, 2020 - 2030 (USD Million)
      1. Reusable Needle-Free Injectors
      2. Disposable Needle-Free Injectors
    4. Global Needle Free Injection Market, By End User, 2020 - 2030 (USD Million)
      1. Hospitals And Clinics
      2. Ambulatory Surgical Centres
      3. Homecare Settings
    5. Global Needle Free Injection Market, By Geography, 2020 - 2030(USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Antares Pharma Inc
      2. Endo Pharmaceuticals Inc.
      3. PharmaJet, Inc
      4. Inovio Pharmaceuticals Inc.
      5. Medical International Technology, Inc
      6. INJEX Pharma GmBH
      7. National Medical Products Inc
      8. European Pharma Group
      9. PenJet Corporation
      10. Valeritas Holdings, Inc
      11. CROSSJECT
      12. MIKA MEDICAL CO.
      13. D'Antonio Consultants International, Inc.
  7. Analyst Views
  8. Future Outlook of the Market